MedPath

Benzodiazepines Deprescribing in Nursing Homes: Intervention Feasibility

Not Applicable
Recruiting
Conditions
Benzodiazepines Deprescribing
Interventions
Other: END-IT intervention for nursing homes
Registration Number
NCT05929443
Lead Sponsor
Université Catholique de Louvain
Brief Summary

The goal of this feasibility study is to evaluate the feasibility of a complex intervention towards benzodiazepines and Z-drugs deprescribing in older adults living in the Belgian nursing home setting.

The main questions it aims to answer are:

* Is the intervention we developped feasible

* To what extent will the intervention be implemented in nursing homes

* To what extent is the design of the recruitment and data collection process feasible and acceptable for all participants

Participants will benefit from a complex intervention implemented at the level of the nursing home, encompassing process and goals setting, healthcare providers education, environmental adaptations, audit and feedback on benzodiazepines use, use of educational leaflet with residents and relatives, and multidisciplinary work.

Researchers will compare this intervention to usual care, to see if the intervention is feasible, and to gather first data on intervention effectiveness in benzodiazepines deprescriping.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria
  • 65 years old and older
  • Taking at least one benzodiazepine or Z-drug for 4 weeks or more
Exclusion Criteria
  • Unability to communicate in French
  • Palliative care
  • Ongoing benzodiazepine withdrawal
  • Ongoing alcohol withdrawal
  • Severe anxiety
  • Severe depression

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
END-IT intervention for nursing homesEND-IT intervention for nursing homesThis complex intervention, implemented at the level of the nursing home, encompasses process and goals setting, education for healthcare providers, environmental adaptations, audit and feedback on benzodiazepine use, use of an educational leaflet for residents and relatives, and multidisciplinary work.
Primary Outcome Measures
NameTimeMethod
Feasibility of the data collection processAt 6 months

Data collection process will be assessed through the quality of collected data (rate of missing data)

Nursing homes' adherence to the interventionAssessed at 6 months

has the intervention been implemented as intended, e.g. global number of implemented intervention components

nursing home residents' responsiveness to the interventionAssessed at 6 months

has far did they respond to the intervention, and how far have them been engaged by the intervention

Feasibility of the recruitment processAt 6 months

The feasibility of the recruitment will be assessed through the ratio between included residents and residents contacted for participation.

Healthcare providers responsiveness to the interventionAssessed at 6 months

has far did they respond to the intervention, and how far have them been engaged by the intervention, e.g level of attendance to education session for healthcare providers

Secondary Outcome Measures
NameTimeMethod
Intervention mechanisms of impactAt 6 months

Use of a questionnaire to assess intervention mechanisms of impact, in relation with how the intervention is supposed to have its impact.

Contextual factors at the level of of the nursing homeBaseline

Use of a questionnaire to assess factors that could explain potential differences in intervention implementation between nursing homes

Contextual factors at the level of the nursing home residentBaseline

Use of a questionnaire to assess factors that could explain potential differences in intervention implementation between nursing home residents

Exploratory benzodiazepine deprescribing rate analysisAt 6 months

Defined as either a complete benzodiazepine/Z-drug cessation, or a dose reduction

Trial Locations

Locations (1)

UCLouvain

🇧🇪

Woluwe-Saint-Lambert, Belgium

© Copyright 2025. All Rights Reserved by MedPath